Current Trend in Drug Resistance Pattern Among Extrapulmonary Tuberculosis Cases at Reference Laboratory of Western India
This cross-sectional study conducted in Western India from 2024 to 2025 analyzed 6,068 extrapulmonary tuberculosis samples and found a 16.43% molecular positivity rate with a 6.11% drug resistance prevalence dominated by rifampicin resistance, underscoring the critical need for universal drug susceptibility testing and enhanced surveillance.